Skip to main content

India Rejects J&J Plea to Extend Patent on Key Tuberculosis Drug, Drop in Prices Expected

The patent on the drug made India dependent on supplies from J&J. The latest decision will pave the way for generic versions in the local market, increasing access

from Top India News- News18.com https://ift.tt/mx6PoJI

Comments

Popular posts from this blog

Coronavirus LIVE Updates: States on Guard for 'Unlock 1' as India Jumps from Rank 9 to 7 Among 10 Countries Worst-hit by Covid-19

Coronavirus LIVE Updates: The Centre's three-phase unlock plan that will restrict curbs to containment zones kicks in from today after the end of the fourth phase of the national lockdown, even as India climbed to the 7th spot from the 9th on 10 countries worst-hit by Covid-19. from Top India News- News18.com https://ift.tt/3dh4Wei